This report focuses on prescribed drug expenditure, which accounts for 85.0% of drug spending in Canada. The first section provides an overview of prescribed drug spending using CIHI’s National Health Expenditure Database (NHEX) data. The second section looks more in-depth at public drug program spending using data from CIHI’s National Prescription Drug Utilization Information System (NPDUIS) Database. 55 pages
It has been reported that up to one-quarter of patients who visit emergency departments (ED) due to adverse drug reactions (ADRs) are admitted to hospital. ADRs resulting in hospital admission generally represent more severe reactions and require more resources to treat. One recent study found that ED visits and hospital admissions due to ADRs among seniors in Canada cost an estimated $35.7 million, with more than 80% of those costs arising from hospitalization.
International Federation on Aging’s report highlights the critical need for action and investment in preventive eye health. By focusing on prevention and early detection of visual impairments, we are promoting a more active and productive older population, which can drive economic activity and mitigate costs of care and other financial burdens associated with ageing and chronic diseases. Across the globe, new policies to improve the diagnosis, management, and care associated with preventable eye diseases – especially among ageing populations – will go a long way in alleviating the burdens triggered by age-related vision loss.
Age related macular degeneration (AMD) accounts for almost 50% of those registered as blind or partially sighted. 1-4 The development of management strategies is limited by the diverse nature of the age related changes and a lack of a clear understanding of the process of visual loss in the elderly. Effective treatment is limited to the management of sub-retinal neovascularisation (SRNV) in selected cases). Despite early expectations that laser treatment might provide significant benefit in preventing blindness 5-7 recurrent disease and progressive visual failure limit the final outcome. 8-9. Early recognition and prevention of potential disease is not as yet applicable to disease other than that related to SRNV.
This white paper identifies the personal and health system burden due to undiagnosed and untreated cases of osteoporosis. The authors highlight the care gap and recommend the need for appropriate assessment and treatment based on the 2010 Clinical Practice Guidelines, through coordinated post fracture care programs using Case Management. 28 Pages.
This website provides information on services, programs and educational resources to promote and protect public health in the prevention of diabetes and resources for those impacted by the disease. Links are provided to the 2013 Clinical BPG and links to tools and other resources for health professionals.